Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods

Cancer. 2008 Nov 15;113(10 Suppl):2841-54. doi: 10.1002/cncr.23758.

Abstract

Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release of an HPV vaccine, as well as increased availability of cancer registry data that now include reporting from a large proportion of the US population, prompted the current assessment of HPV-associated cancers. This article describes methods used to assess the burden of HPV-associated cervical, vulvar, vaginal, penile, anal, and oral cavity/oropharyngeal cancers in the United States during 1998 through 2003 using cancer registry data, and it provides a brief overview of the epidemiology of these cancers.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alphapapillomavirus*
  • Anus Neoplasms / epidemiology
  • Anus Neoplasms / virology
  • Female
  • Genital Neoplasms, Female / epidemiology
  • Genital Neoplasms, Female / virology
  • Humans
  • Male
  • Methods
  • Neoplasms / epidemiology*
  • Neoplasms / virology*
  • Oropharyngeal Neoplasms / epidemiology
  • Oropharyngeal Neoplasms / virology
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / epidemiology
  • Penile Neoplasms / epidemiology
  • Penile Neoplasms / virology
  • Population Surveillance
  • Rectal Neoplasms / epidemiology
  • Rectal Neoplasms / virology
  • Registries*
  • SEER Program
  • United States / epidemiology